Your session is about to expire
← Back to Search
Behavioural Intervention
Music-Based Relaxation for Anxiety in Young Cancer Survivors
N/A
Waitlist Available
Led By Robert Knoerl
Research Sponsored by University of Michigan Rogel Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 3 years from start of study
Awards & highlights
Study Summary
This trial tested a 8-week program of relaxation music to reduce anxiety in young cancer survivors. Results showed it was effective.
Who is the study for?
This trial is for young cancer survivors aged 15-39 who have finished cancer treatment at least a month ago and are experiencing significant anxiety. Participants must be able to speak and read English, and they should score ≥55 on the PROMIS Anxiety 4a scale indicating notable anxiety levels.Check my eligibility
What is being tested?
The study is testing an eight-week virtual program called TiMBRe, which involves tailored music-based relaxation sessions lasting 45 minutes each week, aimed at reducing anxiety in adolescent and young adult cancer survivors.See study design
What are the potential side effects?
Since this intervention involves music-based relaxation techniques delivered virtually, there are no direct medical side effects expected. However, participants may experience varying degrees of emotional response to the relaxation exercises.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 3 years from start of study
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 3 years from start of study
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Acceptability of TiMBRe
Adherence to TiMBRe
Demand of TiMBRe
+1 moreSecondary outcome measures
Change in Anxiety management
Identification of facilitators and barriers to virtual TiMBRe participation
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: TiMBReExperimental Treatment1 Intervention
an eight-week, (45 min/week), theory driven, virtually-delivered, tailored music-based relaxation (TiMBRe) intervention to decrease anxiety in AYA cancer survivors with clinically-relevant anxiety.
Group II: Attention-ControlActive Control1 Intervention
Standard of care study staff calls and cancer survivorship resources
Find a Location
Who is running the clinical trial?
University of Michigan Rogel Cancer CenterLead Sponsor
295 Previous Clinical Trials
24,260 Total Patients Enrolled
Robert KnoerlPrincipal InvestigatorUniversity of Michigan Rogel Cancer Center
1 Previous Clinical Trials
30 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger